Fatema A. Legrand

Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal

Fatema A. Legrand, Douglas F. Nixon, Christopher P. Loo et al. · PLoS ONE · 2006 · 144 citations · Full text

Life Sciences, Immunology, Pediatrics +17

Induction of Potent Humoral and Cell-Mediated Immune Responses by Attenuated Vaccinia Virus Vectors with Deleted Serpin Genes

Fatema A. Legrand, Paulo H. Verardi, Leslie A. Jones et al. · Journal of Virology · 2004 · 64 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Association of high tissue TMB and atezolizumab efficacy across multiple tumor types.

Fatema A. Legrand, David R. Gandara, Sanjeev Mariathasan et al. · Journal of Clinical Oncology · 2018 · 57 citations

Medicine, Oncology, Pharmacology +17

Vaccinia viruses with a serpin gene deletion and expressing IFN-γ induce potent immune responses without detectable replication <i>in vivo</i>

Fatema A. Legrand, Paulo H. Verardi, Kenneth S. Chan et al. · Proceedings of the National Academy of Sciences · 2005 · 34 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Updated efficacy and &gt; 1-y follow up from IMvigor210: Atezolizumab (atezo) in platinum (plat) treated locally advanced/metastatic urothelial carcinoma (mUC).

Robert Dreicer, Jean Hoffman‐Censits, Thomas W. Flaig et al. · Journal of Clinical Oncology · 2016 · 15 citations

Medicine, Oncology, Pharmacotherapy +16